All Entries in the "Dangerous Drugs" Category
Metronidazole injection 500 mg / 100 ml: Voluntary recall due to non-sterility
Non-sterility of metronidazole injection administered via the intravenous route has the potential to result in infections, which could be fatal.
Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
Patients to be informed of risk of severe injection site reactions.
Vita Breath Dietary Supplement
Consumers warned not to use product because it may contain hazardous levels of lead.
GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer
Possible increased risk of diabetes and certain cardiovascular diseases.
McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall
Certain over-the-counter Children’s and Infants’ liquid products may not meet required quality standards.
Atlas Operations, Inc.: Recall of Sexual Enhancement Products
[UPDATED 04/14/2010] Recall expanded to include additional products, sold as a dietary supplements, containing undeclared sulfoaildenafil, which may result in lowering of blood pressure to dangerous levels. Originally posted 12/15/2009
Propylthiouracil
[Updated 04/21/2010] FDA added a Boxed Warning to the label for propylthiouracil,to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients.
Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
FDA is evaluating clinical trial data that may suggest that patients taking Stalevo may be at an increased risk for developing prostate cancer.
MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
Recall of product, sold as a dietary supplement, containing undeclared aildenafil as well as the drug phentolamine.
Zocor (simvastatin): increased risk of muscle injury with high doses
Zocor: Ongoing review shows risk also increased when drug, especially at higher doses, is used with certain drugs.
Cleviprex (clevidipine butyrate): Recall
The recall of 12/2009 has been expanded to include four additional lots. Presence of particulate matter which could potentially reduce blood flow in capillaries, cause mechanical damage to some tissues, or initiate acute or chronic inflammatory reactions.
